- Home
- TIL vs BCHT Comparison
TIL vs BCHT Comparison
Compare TIL & BCHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIL | BCHT |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.4M | 55.2M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | TIL | BCHT |
|---|---|---|
| Price | $7.40 | $1.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $125.00 | $15.00 |
| AVG Volume (30 Days) | 8.0K | ★ 77.0K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $17,626,366.00 |
| Revenue This Year | N/A | $13.42 |
| Revenue Next Year | N/A | $61.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.26 |
| 52 Week Low | $5.67 | $1.26 |
| 52 Week High | $33.83 | $2.48 |
Technical Indicators
Market Signals| Indicator | TIL | BCHT |
|---|---|---|
| Relative Strength Index (RSI) | 51.67 | 36.75 |
| Support Level | $6.91 | $1.26 |
| Resistance Level | $7.50 | $1.55 |
| Average True Range (ATR) | 0.19 | 0.10 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 85.35 | 16.33 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About BCHT Birchtech Corp. Common Stock
Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.